Studying nanocrystalline megestrol acetate for weight loss in cancer
Treatments studied
Part of Cancer clinical trials.
This study tests a special form of the drug megestrol acetate (Megace) in cancer patients who have lost weight and appetite (cachexia). It aims to see if this medication can help improve weight gain and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer.
- You are 18 years or older.
- Your cancer has caused weight loss and poor appetite (cachexia).
- Your body mass index (BMI) is 30 or less.
- You are not currently taking other appetite-boosting medicines or steroids (except for chemotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a drug called nanocrystalline megestrol to standard chemotherapy and immunotherapy can help patients with extensive-stage small cell lung cancer who are losing weight or have poor appetite. It aims to improve nutrition and overall well-being during treatment.
This study tests a new form of megestrol acetate (a medication that helps stimulate appetite and weight gain) for people with advanced liver cancer who are experiencing weight loss or loss of appetite. It is given alongside standard treatments for liver cancer, and the goal is to see if it can improve appetite and quality of life.
This study tests a special form of megestrol acetate (a medicine that can help with appetite and weight gain) in people with advanced digestive system cancers who are about to start or are already taking a type of targeted therapy called a TKI. The goal is to see if it helps with cancer-related weight loss and wasting (cachexia).
This trial tests a drug called megestrol acetate to help people with advanced lung cancer who are losing weight or have poor appetite. It aims to improve nutrition and quality of life.
This study tests a medicine called nanocrystalline megestrol acetate to see if it can help improve appetite and promote weight gain in people with advanced non-small cell lung cancer who are losing weight. If you qualify, you would receive this treatment alongside your regular care to help you feel better and maintain your strength.
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
Hear when a new Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.